Abstract:Objective To investigate the expression and biological behavior of Bcl-2 and autophagy related gene LC3 in bladder urothelial carcinoma cells, and to explore their effects on the prognosis of bladder cancer. Methods Bcl-2 siRNA plasmid was transfected into human bladder transitional cell carcinoma (T24) cells, Western blot and reverse transcription polymerase chain reaction were used to detect the expression of Bcl-2 and LC-3, and to study Bcl-2 knockout. The effect of T24 on the growth and apoptosis of T24 cells in vitro were studied. The expression of Bcl-2 and LC3 in the pathological specimens of cancer tissues were detected, and the prognosis was analyzed. Results Bcl-2 siRNA recombinant plasmid was successfully transfected into T24 cells, the expression of Bcl-2 mRNA was down-regulated by about 80%, the expression of Bcl-2 protein was down-regulated by about 70%, and the mRNA and protein levels of LC3 were down-regulated by about 40%. The protein expression of Bcl-2 and LC3 in the pGenesil-1 Bcl-2 siRNA group was lower than that of the NC group and the empty plasmid group, and the difference was statistically significant (P < 0.05). The cell viability of T24 decreased to (66.8±5.8) %, and the cell apoptosis rate was 56.68%. The cell viability of the pGenesil-1 Bcl-2 siRNA group were higher than those of the empty plasmid group and the NC group, and the differences were statistically significant (P < 0.05). There was a statistically significant difference in the positive rate of LC3 expression between normal bladder tissue and bladder cancer (P < 0.05). The positive rate of Bcl-2 protein expression in normal bladder tissue and bladder urothelial carcinoma was compared, and the difference was statistically significant (P < 0.05). The expression of LC3 protein in bladder urothelial carcinoma samples of different grades and stages was compared, and the difference was statistically significant (P < 0.05). There was a statistically significant difference in the expression of Bcl-2 protein in bladder urothelial carcinoma samples with or without lymph node metastasis (P < 0.05). Conclusion Down-regulation of Bcl-2 gene will reduce the expression level of bladder cancer cell LC3, inhibit cell growth and promote its apoptosis. The combination of Bcl-2 and LC3 helps to judge the prognosis of bladder urothelial carcinoma.
周万里1 张建平1▲ 潘永昇2 徐卫东1. Bcl-2和LC3对膀胱癌发生发展及预后的相关性分析[J]. 中国医药导报, 2020, 17(34): 43-47.
ZHOU Wanli1 ZHANG Jianping1▲ PAN Yongsheng2 XU Weidong1. Analysis on the correlation between Bcl-2 and LC3 on the development and prognosis of bladder cancer. 中国医药导报, 2020, 17(34): 43-47.
[1] Bruins HM,Veskim?覿e E,Hernández V,et al. The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer:A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel [J]. Eur Urol Oncol,2020,3(2):131-144.
[2] Kamoun A,de Reyniès A,Allory Y,et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer [J]. Eur Urol,2020,77(4):420-433.
[3] Rodriguez Pena MDC,Chaux A,Eich ML,et al. Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder [J]. Virchows Arch,2019,475(3):349-356.
[4] Lee HY,Chen YJ,Chang WA,et al. Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma-Next-Generation Sequencing and Bioinformatics Approaches [J]. Medicina (Kaunas),2019,55(12):768.
[5] Merten R,Ott O,Haderlein M,et al. Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta,Tis,T1,T2) [J]. Oncologist,2019,24(12):e1341-e1350.
[6] Kojima T. Editorial Comment from Dr Kojima to Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer:Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection,induction chemoradiotherapy and partial cystectomy [J]. Int J Urol,2019,26(10):1012.
[7] Zhou Z,Meng M,Ni H. Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases [J]. Med Sci Monit,2017,23:462-469.
[8] Li F,Pascal LE,Zhou J,et al. BCL-2 and BCL-XL expression are down-regulated in benign prostate hyperplasia nodules and not affected by finasteride and/or celecoxib [J]. Am J Clin Exp Urol,2018,6(1):1-10.
[9] Quan Y,Lei H,Wahafu W,et al. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer [J]. Biomed Pharmacother,2019,120:109490.
[10] Schaaf MB,Keulers TG,Vooijs MA,et al. LC3/GABARAP family proteins:autophagy-(un)related functions [J]. FASEB J,2016,30(12):3961-3978.
[11] Osman AK,Shintani M. Autophagy in normal tissues of camel (Camelus dromedarius) with focus on immunoexpression of LC3 and LC3B [J]. Biotech Histochem,2018,93(8):557-564.
[12] Wu DJ,Adamopoulos IE. Autophagy and autoimmunity [J]. Clin Immunol,2017,176:55-62.
[13] 王佳贺,王超.细胞自噬对岩大戟内酯B诱导的白血病细胞HL-60凋亡的影响[J].中国医药导报,2018,15(28):13-16.
[14] 张浩然,乔旭旭,毕明宏.哺乳动物雷帕霉素靶蛋白介导细胞自噬在肿瘤中的研究进展[J].中国医药导报,2018,15(25):32-35.
[15] Jafargholizadeh N,Zargar SJ,Agtabi Y. Upregulate the LC3 gene and induce cell-cycle arrest in human gastric cancer cell line AGS [J]. Iran J Basic Med Sci,2018,21(3):253-259.
[16] Lin YC,Lin JF,Wen SI,et al. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis [J]. Gaoxiong Yi Xue Ke Xue Za Zhi,2017,33(5):215-223.
[17] Qiu W,Su M,Xie F,et al. Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells [J]. Cell Death Dis,2014,5(3):e1123.
[18] Wu X,Zheng Y,Yang D,et al. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy [J]. J Mater Chem B,2019,7(3):477-487.
[19] Wang C,Chen K,Xia Y,et al. N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway [J]. PLoS One,2014,9(9):e108855.
[20] Jiang P,Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells [J]. Methods,2015,75:13-18.
[21] Runwal G,Stamatakou E,Siddiqi FH,et al. LC3-positive structures are prominent in autophagy-deficient cells [J]. Sci Rep,2019,9(1):10147.
[22] Meng YC,Lou XL,Yang LY,et al. Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma:a meta-analysis [J]. J Cancer Res Clin Oncol,2020, 146(5):1103-1113.
[23] Sengupta P,Chattopadhyay S,Chatterjee S. G-Quadruplex surveillance in BCL-2 gene:a promising therapeutic intervention in cancer treatment [J]. Drug Discov Today,2017,22(8):1165-1186.
[24] Suvarna V,Singh V,Murahari M. Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy [J]. Eur J Pharmacol,2019,862:172655.
[25] Liang M,Zhao J. Protein expressions of AIB1,p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis [J]. Eur Rev Med Pharmacol Sci,2018,22(16):5134-5139.
[26] Weidberg H,Shvets E,Shpilka T,et al. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis [J]. EMBO J,2010, 29(11):1792-1802.